EVALUATION OF COGNITIVE EFFECTS OF ECT (PRELIMINARY OBSERVATIONS) by Bagadia, V. N. et al.
Indian J. Psychiat. (1981), 23(4), 324—329 
EVALUATION OF COGNITIVE EFFECTS OF ECT (PRELIMINARY 
OBSERVATIONS) 
V. N. BAGADIA
1, M.D., D.P.M., F.A.P.A., F.R.C. Psych. 
L. P. SHAH', M.B.B.S., D.P-H, F.A.P.A., M.R.G. Psych. 
P. V. PRADHAN', M.D., D.P.M. 
JVOT1 DOSHI', M.A., Dip. V.G. 
RAVI ABHYANKAR*, M.D., D.P.M., M.N.A.M.S. 
SUMMARY 
The aim of present double blind controlled study is to evaluate the effects of ECT in Schizophrenia 
and Depression. 20 depressed and 20 schizophrenic patients of either sex, in the age group 18 to 65 years 
fulfilling the inclusion and exclusion crciteria were taken for study. The psychiatric evaluations were carried 
out before the treatment, and at the end of 3, 6, 8 and 10 treatments. Cognitive test battery was adminis-
tered before the treatment and 48 hours after the last treatment. No Post ECT cognitive deficit was observed 
on the test battery though some patients did complain of forgetfulness subjectively. 
Electroconvulsive therapy has become 
controversial in recent times and is used 
less frequently in western countries. Post-
ECT memory deficiency is one of the 
important reasons for non-acceptance of 
ECT. But in India and other developing 
countries ECT is used commonly because 
of rapid improvement and more economical. 
It is used quite commonly to treat depres-
sion and schizophrenia, as well as mania. 
A double blind controlled s'udy has been 
conducted to re-evaluate the effects of 
ECT in schizophrenia and depression. The 
present report on cognitive side effects of 
ECT is a part of this ongoing project. 
MATERIAL AND METHOD 
Depressed and schizophrenic patients 
of either sex, in the age group 18 to 65 
years from our psychiatric O.P.D. at the 
K.E.M. Hospital, Bombay were taken up 
for study. A detailed psychia'ric history, 
mental status and physical examination 
were cairied out and recorded in a pro-
forma devised for the purpose. Only 
those patients in whom diagnosis was agreed 
upon by two consultant psychiatrists through 
independent evaluations and those who 
fulfilled the inclusion criteria were taken 
up for study. 
The inclusion criteria for depression 
were (i) clear primary depression of non-
organic cause, (ii) a score of at least 16 
on Hamilton's Rating Scale for Depression 
(consisting of 17 items) and (iii) a score 
of at least 12 points on Beck's Self Inventory 
for depression (short-form). 
The inclusion criteria for schizophrenia 
were (i) An illness of at least one month's 
duration, (ii) Presence of delusions, hallu-
cinations or irrelevant verbal production 
with clear consciousness and (iii) Absence 
of depressive or manic symptoms sufficient 
to qualify for schizoaffective or affective 
illness. 
The exclusion criteria were treatment 
within previous three weeks with anti-
depressant and antipsychotic drugs, within 
previous eight weeks with ECT or Insulin 
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therapy, organic brain syndrome, convulsive 
disorder, and any physical illness. 
A double blind randomized technique 
was used in two parallel groups of patients. 
The depressed patients were assigned either 
to group A which received ECT and placebo 
or group B which received simulated ECT 
and imipramine as treatment. The schizo-
phrenic patients were assigned to group 
A which received ECT and placebo or 
group B which received simulated ECT-
chlorpromazine treatment. 
To administer ECT each patient was 
anaesthetized with (i) Atropine 0.6 mg. i.v. 
(ii) Thiopentone 250 mg. i.v. and (iii) 
Succinylcholine 50 mg. i.v. Convulsion 
was induced by an electrical stimulus of 
110 volts A.C. for approximately 0.5 sec. 
using bilateral bitemporal electrode place-
ment. Patients were supported by artificial 
ventilation and oxygenation before and 
after electric stimulus. Exactly same pro-
cedure was used for simulated ECT except 
that no electrical stimulus was given. Three 
treatments, ECT or simulated ECT were 
given in the first week and two per week 
thereafter. The consultant psychiatrist who 
was blind to the mode of treatment eva-
luated the patients and advised on the 
number of treatments to be given. 
The drugs used were imipramine 25 
mg. tablet for depression, chlorpromazine 
100 mg. tablet for schizophrenia and cal-
cium lactate 300 mg. tablet as placebo. 
The initial dose of 3 tablets per day was 
gradually increased to 6 tablets per day 
at the end of one week. Thereafter the 
dose was maintained, increased or decreased 
after evaluations by the consultant psy-
chiatrist who was blind to the mode of 
treatment. Chloral hydrate as a hypnotic 
The standard RDC (Research Diagnostic Cri-
teria) recommend at least six months duration. As 
about 50% of the Schizophrenic patients attending 
our clinic are ill for less than six months, this criteria 
was modified to make the study sample more repre-
sentative of the clinic population. 
and chlordiazepoxide to control anxiety/ 
agitation in depressed patients were used 
whenever required. 
Following psychiatric evaluations were 
carried out before the treatment and at the 
end of 3, 6, 8 and 10 treatments— 
(1) Hamilton's Rating Scale and Beck's Self 
Inventory for Depression, (2) Brief Psy-
chiatric Rating Scale for Schizophrenia, 
(3) Clinical Global Assessment and (4) 
Clinical and subjective evaluations of side 
effects. 
The Cognitive Test Battery was ad-
ministered before the treatment and 48 
hours after last treatment. It consisted of 
Koh's Block, Recognition and B.G. tests 
for the nondominant hemispheric functions 
and Arithmetic, Immediate memory (digits), 
Sentence Repetition, Remote memory and 
recent memory tesis for the dominant 
hemispheric functions. 
SAMPLE 
Thirty-five depiessed and thirty-three 
schizophrenic patients were initially in-
cluded in the study. Fifteen depressed 
patients and thirteen schizophrenic patients 
were excluded for following reasons—irre-
gular attendance, non-compliance in taking 
drugs in adequate dose and discontinuation 
of treatment. The drop out rate was 
similar both in ECT and simulated ECT 
groups.- The data from 20 depressed (10 
in ECT and Placebo group and 10 in simu-
lated ECT and Imipramine group) and 
20 schizophrenic (12 in ECT and placebo 
group and 8 in simulated ECT and Chlor-
promazine group) patients who completed 
the entire study form the basis of this 
paper. 
RESULTS 
Demographic variables 
The number of female patients was 
more in Depression (ECT-placebo) group. 
There was no significant difference in the 
groups with regard to age, marital status, 326  V. N. BAGADIA et al. 
education, per capita income, duration of 
episode, total number of episodes and total 
duration of illness. 
ECT Variables 
One depressed patient was adminis-
tered 8 EGT's. Rest of the depressed 
patients were administered 6 EGT's or 
simulated ECT. 6 schizophrenics were 
administered 6 ECT's and 3 each were 
administered 8 and 10 ECT's. 3 schizo-
phrenics were administered 6 simulated 
ECT's, 3 received 8 simulated ECT's and 
2 received 10 simulated ECT's. 
Drag Variables 
All the depressed patients on simulated 
ECT received up to 150 mg. of imipramine 
per day. 2 patients on ECT and 4 patients 
on simulated ECT required chlordiaze-
poxide (20-40 mg/day) to control their an-
xiety or agitation. One schizophrenic patient 
on simulated ECT was advised 900 mg. of 
chlorpromazine per day. All other patients 
received up to 600 mg. of chlorpromazine 
per day. 
Effects on Cognitive Functions 
Cognitive side effects of ECT and 
simulated ECT are presented in terms of 
mean percent change in the pretreatment 
and post-treatment scores on each of the 
8 tests of the cognitive battery in the four 
groups, i.e. (1) Depiessed patients receiving 
ECT and placebo. (2) Depressed patients 
receiving simulated ECT and imipramine, 
(3) Schizophrenic patients receiving ECT 
and placebo and (4) Schizophrenic patients 
receiving simulated ECT and chlorpro-
mazine. 
Depression : ECT and Placebo Group (Table 1) 
Ihere is improvement in the post-
tratment score on all the tests of cognitive 
battery except arithmetic test (Reduced 
score on B.G. test deno'es improvement). 
The improvement in the Koh's Block Design 
test is significant (p<0.01). 
TABLE No. 1—Depression—ECT and Placebo 
A. Koh's Block De-
sign Test 
B. Picture Recog-
nition test 
C. B.G. Test 
D. Arithmetic Test 
Group 
N 
9 
10 
9 
10 
E. Immediate memory 10 
F. Sentence Repe-
tition Test 
G. Remote memory 
H. Recent memory 
10 
10 
10 
Mean 
Percent 
Change 
52.22 
1.8 
—4.67 
—2.2 
6.2 
29 
0 
5.3 
S.D. 
50.39 
11.12 
39.04 
14.79 
16.48 
61.06 
0 
11.58 
t value 
2.93* 
0.48 
0.03 
0.04 
1.13 
1.42 
0 
1.37 
•p<0.01. 
Depression : Simulated ECT and Imipramine 
Group (Table 2) 
There is improvement in the post-
treatment scores on all the tests of cognitive 
battery except Arithmetic test. Both the 
improvement in the Koh's Block Design 
test and the deterioration in the arithmetic 
test are significant (p<0.05). 
TABLE No. 2—Depression—Simulated ECT 
and Imipramine Group 
N 
Mean 
Percent 
change 
S.D. t value 
2.77* 
A. Koh's Block De-
sign Test . . 10 44.08 48.43 
B. Picture Recog-
nition Test .. 10 6.9 22.58 0.92 
C. B.G. Test .. 10 —7.8 19.13 1.22 
D. Arithmetic Test 10—10.3 11.36 7.72* 
E. Immediate memory 10 0.2 10.77 0.05 
F. Sentence Repe-
tition Test .. 10 4.2 14.59 0.86 
G. Remote memory 10 5.8 13.37 1.41 
H. Recent Memory 10 0 0 0 
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Schizophrenia : ECT and Placebo Group (Table 
3) 
There is improvement in the post-
treatment scores on all the tests of cognitive 
battery except sentence repetition test. The 
improvement in Koh's Block Design test 
is significant (p<0.05). 
TABLE No. 3— Schizophrenia—ECT and 
Placebo group 
Mean 
N Percent S.D. t value 
change 
A. 
B. 
C. 
D. 
E. 
F. 
G. 
H 
Koh's Block De-
sign Test 
Picture Recog-
nition Test 
B.G. Test 
Arithmetic Test 
10 
10 
11 
12 
Immediate memory 12 
Sentence Repe-
tition Test 
Remote memory 
. Recent memory 
10 
11 
12 
38.5 
66.2 
—7.91 
11.17 
10.33 
—0.9 
24.18 
16 
33.2 
123.06 
24.60 
18.00 
18.83 
28.92 
39.31 
47.13 
3.47* 
1.61 
1.06 
2.06 
-1.82 
0.09 
1.94 
1.13 
*p<0.05. 
Schizophrenia : Simulated ECT and Chloro-
promazine Group (Table 4) 
There is improvement in the post-
treatment scores on all the tests of cognitive 
battery. The improvement on Koh's Block 
Design test is significant (p<0.05). 
Comparison between ECT and Placebo group 
and Simulated ECT and Drug Group 
Both in the depressed and schizophrenic 
patients (in the improved as well as unim-
proved) there was no significant difference 
as regards the scores on cognitive test 
battery. 
Comparison between the test scores 
of dominant and non-dominant hemispheric 
functions revealed no significant difference. 
Forgetfulness as Subjective Complaint (Table 5) 
Forget fulness was complained by 5 
schizophrenics who received ECT. 2 of the 
TABLE No. 4—Schizophrenia—Simulated 
ECT and Chlorpromazine Group 
Mean 
N Percent S.D. t value 
change 
A. 
B. 
C. 
D. 
E. 
F. 
C. 
H. 
Koh's Block De-
sign Test 
Picture Recog-
nition Test 
B.G. Test 
Arithmetic Test 
Immediate memory 
Sentence Repe-
tition Test 
Remote memory 
. Recent memory 
6 
8 
8 
8 
8 
8 
7 
8 
20.1 
6.25 
—3.37 
20.13 
17.35 
16.12 
16.71 
3.12 
15.8 
17.2 
33.9 
22.98 
30.55 
22.14 
39.05 
8.84 
2.65* 
1.03 
0.28 
2.32 
1.50 
1.94 
1.05 
0.93 
*p<0.05. 
TABLE NO. 5—Forgetfulness as Subjective 
Complaint—Schizophrenia Group 
Simulated 
ECT Group ECT 
Group 
No. of ECT No. of ECT 
6 8 10 6 8 10 
Clinical Improvement 
present . . ..210010 
No Clinical Improvement 0 0 2 0 10 
Depression Group 
Forgetfulness was complained by 1 patient who 
had clinically improved after 6 ECT. 
patients had no clinical improvement after 
10 ECT. Of the other three patients with 
forgetfulness, 2 had improved after 6 ECT 
and 1 had improved after 8 ECT. For-
getfulness was complained by 2 schizo-
phrenics who had received simulated ECT. 
Both had received 8 simulated ECT treat-
ments, one of them had improved and the 
other had no clinical improvement. One 
depressed patient complained of forget-
fulness. He received 6 ECT and had 328  V. N. BAGADIA et al. 
improved clinically. The forgetfulness was 
regarding inability to recall messages, tele-
phone numbers, names, etc. which were 
learned in past few days. 
No deficit in the scores of the cognitive 
test battery was present in any of the 
patients who complained of forgetfulness. 
As a group, their scores were not signifi-
cantly different than the patients who 
did not complain of forgetfulness. 
DISCUSSION 
In the present study no cognitive 
deficit in the tests administered was ob-
served after ECT ; moreover there was 
significant improvement in the scores on 
Koh's Block design test. Fink (1977), 
Hamilton et al. (1979) and Weeks 
et al. (1980) have also reported lack 
of cognitive deficit after ECT. Weeks 
et el. (1980) have suggested a bidirectional 
response to explain this observation of im-
paired cognitive functions in schizophrenia 
and depression, improve subsequent to the cli-
nical improvement produced by ECT. This 
effect may mask the deterioration produced 
by the effect of ECT perse. The improve-
ment in the cognitive functions is more 
evident on performance tests, which reveal 
greater initial impairment. Summers et 
al. (1979) have postulated that like ECT, 
psychotropic drugs also exhibit a bidirec-
tional response. 
In spite of lack of memory impair-
ment on the test battery, 20% of the patients 
did have a subjective compliment of forget-
fulness. Similar observations were made 
by Fink (1979) who noted that learning is 
improved after ECT and retention is im-
paired. Recognition is least affected and 
recall after an interpolated delay is worst 
affected (Squire, 1977). 'Ihe subjective 
forgetfulness was regarding inability to re-
call material learned in the past few days; 
which generally did not interfere in inter-
personal, social or vocational functions. 
Further work needs to be done to find out 
objective parameters of the subjective for-
getfulness. 
In the present study, 40% of schizo-
phrenics who received ECT complained 
of forgetfulness as against 10% of depressives 
who complained of forgetfulness after ECT. 
This could be related to the psychopathology. 
The hall mark of schizophrenia, primary 
thought disturbance is last and least to 
improve after any treatment including ECT. 
The complaint of forgetfulness observed in 
them may be a subjective attempt to explain 
the schizophrenic thought disturbance. Psy-
chomotor relardation and slowness of think-
ing observed in depression, a primarily 
affective disorder would disappear com-
pletely when depression improves. Thus 
the complaint of forgetfulness would be 
uncommon. 
In one of our earlier studies (Bagadia 
et al., 1980) 62.8% depressed patients had 
complained of forgetfulness when 6 unmodi-
fied ECT, were administered every alternate 
day without any artificial ventilation and 
oxygenation. In a subsequent study, where 
artificial ventilation and oxygenation was 
not used but adequate spacing was given, 
20% of the depressed patients complained 
of forgetfulness after 6 unmodified 
ECT (Bagadia et al., 1980). In 
the present study where both adequate 
spacing as well as artificial ventilation and 
oxygenation was used, 10% of depressives 
complained of forgetfulness. It appears 
that spacing the treatments and oxygena-
tion reduces the complaint of forgetfulness. 
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